S&P 500 7718.60 -0.38%
NASDAQ 26506.99 -0.29%
TASI 11024.73 -0.40%
Oil (WTI) 91.48 +0.00%
Oil (Brent) 96.28 +0.00%
VIX 15.30 +5.30%
Gold 4476.60 +0.00%
USD/SAR 3.76 +0.02%

Pfizer Inc.

PFE · Healthcare · · USD
28.45 USD
0.00 (-1.25%)
● Updated 2026-09-07 20:34 Saudi Time ↻ Refresh
Short-term Mid-term Long-term

Fahodi Score BUY Short-term (Swing)

73
/ 100
Technical 75
Trend & RS 90
Momentum 63
Fundamental (0%) 56
Macro 64
Liquidity 48
ComponentScoreWeight
Technical 75.0 40%
Trend & RS 89.5 20%
Momentum 63.1 20%
Fundamental 55.6 0%
Macro 64.4 15%
Liquidity 47.9 5%

Trade Setup

Entry 28.45
Stop Loss 27.27 (4.2%)
Target 1 (1:1) 29.63 (+4.2%)
Target 2 (2:1) 30.81 (+8.3%)
ATR(14) 0.59 (2.1%)
Risk per Share 1.18
Reward:Risk 2:1

ATR-based levels. Adjust for support/resistance zones.

Factor Profile

Factor Score Z Bar
Value 56.6 +0.26
Momentum 63.1 +0.53
Quality 28.5 -0.86
Composite 49.4

Quality Scores

Piotroski F-Score 5 /9 — Average
✓ ✓ ✗ ✗ ✓ ✗ ✓ ✓ ✗
1. Positive Net Income 2. Positive Roa 3. Positive Cfo 4. Quality Earnings 5. Lower Leverage 6. Higher Liquidity 7. No Dilution 8. Higher Gross Margin 9. Higher Asset Turnover
Altman Z-Score Insufficient Data

Valuation vs Peers Fair Value

MetricStockSectorvs Peers
P/E Ratio 37.4 22.0 +70% above
P/B Ratio 1.9 4.0 Below
Dividend Yield 6.0% 1.5% Above avg

Comparing against Healthcare median multiples.

Intrinsic Value (DCF) Significantly Overvalued

Intrinsic Value
9.63
vs
Market Price
28.45
Upside
-66.2%
Margin of Safety -195.5%
Stage 1 PV (5yr FCF)14,503,575,389
Terminal Value PV40,380,195,497
Total Enterprise Value54,883,770,886

Assumptions

Base FCF3,465,401,781
Growth Rate (5yr)2.6%
Terminal Growth2.5%
Discount Rate (WACC)9.0%

2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.

Position Sizing — Kelly Criterion

4.5%
Recommended Size
47.29%
Full Kelly
23.64%
Half Kelly
5.0%
Max Cap (Moderate)

Kelly inputs derived from quant score 73/100. Estimated win rate 62%, avg win 9.4%, avg loss 3.5%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.

BEAR Regime: BEAR (20% confidence) — position size reduced 10%

Signal Summary STRONG BUY

3
Bullish Signals
1
Bearish Signals
63.2
RSI(14)
0.8057
MACD

Relative Strength (RS) IMPROVING

73
/ 99
RS Rating
O'Neil filter: <80
RS vs SPY ↑ RISING (+6.5% vs SPY 3M)
RS vs Sector OUTPERFORMING (Healthcare)
RS New High No (2d since high)
Sector Outperformance +3.4% (3M)
RS Line — stock / SPY (90 bars)
← older newer →
RS vs SPY 50-day SMA of RS
IMPROVING: Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.

Technical Indicators

IndicatorValueSignal
Rsi 63.2 NEUTRAL
Macd 0.8057 BEARISH
Ma Cross 25.82 / 25.45 GOLDEN CROSS
Trend Short ABOVE SMA50
Trend Long ABOVE SMA200
Bollinger MIDDLE
Volume 0.68x NORMAL

Key Levels

LevelPrice
52-Week High29.21
Bollinger Upper29.42
SMA(200)25.45
SMA(50)25.82
SMA(20)27.79
Current Price28.45
Bollinger Lower26.17
52-Week Low23.58
ATR(14)0.59

Advanced Technical Analysis

Click to expand

Wyckoff Phase & Volume Spread Analysis

Wyckoff Phase

MARKUP Confidence
100%
Acc: 0.0  |  Dist: 0.0  |  Markup: 2.0  |  Markdown: 0.0

Volume Spread Analysis (last 5 bars)

DateSignalVolDescription
2026-08-31 Normal 1.32x Normal bar — no special VSA pattern
2026-09-01 Normal 1.22x Normal bar — no special VSA pattern
2026-09-02 Normal 1.13x Normal bar — no special VSA pattern
2026-09-03 Normal 0.77x Normal bar — no special VSA pattern
2026-09-04 Normal 0.68x Normal bar — no special VSA pattern

Ichimoku Cloud BULLISH

LineValueStatus
Tenkan-sen (9) 28.43 Above Kijun
Kijun-sen (26) 26.94 Base line
Senkou A 27.68 Leading span A
Senkou B 26.21 Leading span B
Cloud 26.21 – 27.68 Bullish (Green)
Price vs Cloud 28.45 Above Cloud
Chikou Span 25.01 Bullish
Alignment Score 4/4 BULLISH

TTM Squeeze & Divergences

TTM Squeeze

SQUEEZE OFF No squeeze Momentum: BULLISH FADING
BB: 26.17 – 29.42  |  KC: 26.88 – 28.71

Divergences (last 60 bars)

TypeIndicatorBars AgoStrength
Regular Bearish RSI 9
Regular Bearish MACD 13

Anchored VWAP

VWAP: 24.85 Anchor: 2025-09-25 (52w Low) ABOVE AVWAP +14.5%

Heikin-Ashi Trend

WEAKLY BEARISH Full data via /api/advanced/PFE

Valuation

MetricValue
Market Cap162.16B
P/E (TTM)37.43
Forward P/EN/A
P/B1.90
EPS0.76

Financial Health

MetricValue
Revenue Growth2.6%
Profit Margin6.8%
ROE5.0%
Debt/Equity74.25
Current Ratio1.27
Dividend Yield6.0%
Payout RatioN/A
Beta0.30

Trading Data

28.45
Open
28.45
Day High
28.45
Day Low
23.53M
Volume (0.6x avg)

Recent News (8)

Forget the Dividend. This Could Be the Real Reason to Buy Pfizer Stock Now
24/7 Wall St. · 2026-09-07
This Is What I'd Do With Pfizer Stock Right Now
Motley Fool · 2026-09-07
Here's How Trump's Drug Deals Are Likely to Impact Healthcare ETFs
Zacks · 2026-09-07
AstraZeneca Secures FDA Nod for New Breast Cancer Therapy Etcamah
Zacks · 2026-09-07
AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026?
Motley Fool · 2026-09-04
Was JNJ Stock Rally Actually Its Own?
Trefis · 2026-09-04
Pfizer’s Stock Has Been Crushed—Is Its 6% Dividend Finally Worth Buying?
24/7 Wall St. · 2026-09-04
AMGN's MariTide: Can Convenience Drive its Obesity Market Share?
Zacks · 2026-09-04

Price Chart (90 Days)

Candlesticks (green=up, red=down) SMA 20 SMA 50 Bollinger Bands (upper/lower) Volume (green=buying, red=selling)
Powered by Fahodi Methodology. This is analytical output, not financial advice. Always do your own due diligence.  ·  Pipeline status  ·  Data: —